Helius Medical Technologies Announces Preliminary CMS Payment Determination of Reimbursement For Portable Neuromodulation Stimulator
Portfolio Pulse from Benzinga Newsdesk
Helius Medical Technologies announced that the Centers for Medicare & Medicaid Services (CMS) has released its preliminary Medicare payment determinations for the PoNS Controller and Mouthpiece, indicating a positive step towards reimbursement for these devices.
May 06, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The preliminary CMS payment determination for the PoNS Controller and Mouthpiece represents a significant regulatory milestone for Helius Medical Technologies, potentially leading to increased adoption and sales.
The preliminary payment determination by CMS is a critical step in the process of securing reimbursement for medical devices. This decision directly impacts Helius Medical Technologies by potentially increasing the accessibility of their PoNS devices to a broader Medicare population, which can significantly boost the company's revenue and market penetration in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100